Get the latest news on Adyen stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ADYEY performance

Latest Adyen Stock News | OTC:ADYEY | Benzinga

Adyen is a payment company that provides merchants with a single platform to accept e-commerce, mobile, and point-of-sale payments in multiple countries using various payment schemes and methodologies. Adyen started out providing only gateway and payment processing services to merchants but soon expanded into merchant acquiring services as well. Adyen obtained a banking licence to improve settlement of merchant accounts.

San,Francisco,,Ca,,Usa,,March,15,,2021:,Stripe's,Application,Login

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Long Ideas

Markets

Analyst Ratings

Tech

Trading Ideas

$PYUSD

ADYEY

ARKF

FINX

PYPL

SHOP

TOST

Stripe&#39;s growth is outpacing competitors, processing $1.4 trillion in volume last year, thanks in part to its role as the payment backbone for AI companies and focus on stablecoins.

Stripe&#39;s Payment Surge Puts Adyen, PayPal, Fiserv On Notice - AI, Stablecoins Fuel The Race

Cathie Wood-Led Ark Invest Dumps $7M Worth Of Palantir Stock Amid Searing Rally

Equities

News

ETFs

ACCD

ACHR

ARKG

ARKK

ARKQ

ARKX

EXAS

IRDM

RXRX

TWST

Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.

Cathie Wood&#39;s Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday

Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up

Biotech

ARKW

AVAV

CRSP

RBLX

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

Cathie Wood&#39;s Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox

Adyen NV

Press Releases

TravelPerk acquires AmTrav to accelerate US expansion and announces new $135m backing from Blackstone and Blue Owl

Fintech

Global Fintech Adyen Recognized as a Leader in the IDC MarketScapes for Worldwide Retail Online Payment Platform Software Providers and Worldwide Retail Omni-channel Payment Platform Software Providers

Entertainment

Contracts

General

Aghanim and Adyen Form Strategic Partnership to Power Direct-to-Consumer Payments for Mobile Games

Adyen's Intelligent Payment Routing Achieves 26% Cost Savings and Improves Payment Performance on US Debit Transactions

Crate & Barrel Partners with Adyen to Streamline Payments, Unifying In-Store and Online Experience

Adyen To Power Omnichannel Payments at U.S. Cinemark Theaters

Adyen continues to pioneer the in-person payment space with host of new industry-defining products

Adyen and BCG Research Finds Embedded Payments and Finance Now a $185 Billion Opportunity -- a 25% Increase in Two Years

Introducing Adyen Uplift: The payment solution optimizing every transaction with AI

Adyen

<a href="https://www.benzinga.com/topic/stripe">Stripe</a> just pulled off a massive growth spurt, and <a href="https://www.benzinga.com/topic/payments">the payments giants</a> should be paying attention. According to JPMorgan analyst Tien-tsin Huang, the private fintech powerhouse processed a staggering $1.4 trillion in volume last year, a 38% year-over-year jump that left competitors in the dust. 



For context, Huang highlights that Stripe's incremental volume growth alone &#8211; $400 billion &#8211; was more than a quarter of Visa Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) and Mastercard Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) combined growth and nearly twice the annual gross payment volume (GPV) of Block Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) and Toast Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) combined.



<h2 class="wp-block-heading">Stripe's AI Play: The Payment Backbone Of OpenAI &amp; Anthropic</h2>



If AI is the future, Stripe is already its financial backbone. Huang points out that every AI company on the Forbes AI 50 that sells online &#8211; OpenAI, Anthropic, Midjourney, Perplexity, and others &#8211; processes payments through Stripe. 



He notes that these AI firms are scaling at unprecedented speeds, with the top 100 AI startups on Stripe reaching $5 million in annualized revenue within 24 months, compared to 37 months for SaaS firms in 2018.



For investors seeking exposure to this AI-driven payments boom, Huang sees potential in publicly traded payment giants. The Global X FinTech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINX#NYSE">FINX</a>) and ARK Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) hold stakes in key Stripe competitors like PayPal Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), Block and Adyen NV (OTCOK:ADYEY).



Read Also: <a href="https://www.benzinga.com/25/02/43942860/paypal-eyes-double-digit-eps-growth-by-2027-teams-up-with-verifone-jp-morgan-more">PayPal Eyes Double-Digit EPS Growth By 2027, Teams Up With Verifone, J.P. Morgan &amp; More</a>



<h2 class="wp-block-heading">Stablecoins: The Next Big Payments Battleground</h2>



Huang also highlights Stripe's growing focus on Stablecoins, which took a leap forward with last month's acquisition of Bridge. Unlike past crypto hype cycles, Stripe sees real-world use cases: corporate treasury, remittances, and payments in low-card penetration markets. 



Huang notes that PayPal's $PYUSD stablecoin is already advancing in this space, raising the question of whether Stripe's move will accelerate adoption across the industry.



With Stripe increasingly competing against Adyen, PayPal's Braintree, and Fiserv Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) Carat, Huang sees a rapidly shifting payments landscape.



Investors should closely monitor how public fintech players respond—because Stripe's expansion isn't slowing down.



Read Next: 



<ul>
<li><a href="https://www.benzinga.com/25/02/43969083/paypal-shifts-focus-from-payments-to-commerce-amid-growth-strategy-analysts-urge-caution">As PayPal Shifts Focus From Payments To Commerce, Analysts Urge Caution Amid &#8216;Ambitious&#8217; Plans</a></li>
</ul>



Image Via Shutterstock

Stripe's Payment Surge Puts Adyen, PayPal, Fiserv On Notice - AI, Stablecoins Fuel The Race

On Friday, Feb. 28, 2025, Cathie Wood&#8217;s&nbsp;Ark Invest&nbsp;made some notable trades. The most prominent among these were the purchases of&nbsp;Archer Aviation Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>),&nbsp;Recursion Pharmaceuticals Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>),&nbsp;Tempus AI Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), and&nbsp;Iridium Communications Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>).



On the other hand, Ark Invest decided to offload shares of&nbsp;Twist Bioscience Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>),&nbsp;Adyen NV&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>),&nbsp;Accolade Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and&nbsp;Exact Sciences Corp&nbsp;(NCM: EXAS).



The ACHR Trade



Ark Invest purchased a significant number of shares in&nbsp;Archer Aviation Inc&nbsp;across three of its ETFs. The ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) bought 360,583 shares, the ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>) acquired 54,699 shares, and the ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) added 17,322 shares.



Based on the closing price of $8.88 on Friday, the total value of these trades is approximately $3.8 million.



The RXRX and TEM Trades



Ark Invest also showed a strong interest in&nbsp;Recursion Pharmaceuticals Inc&nbsp;and&nbsp;Tempus AI Inc. Ark Invest <a href="https://www.benzinga.com/markets/equities/25/02/43963343/cathie-woods-buys-the-dip-in-tempus-ai-coinbase-but-sells-arks-bitcoin-etf-shares-amid-crypto-meltdown">previously purchased</a> a substantial number of shares in Tempus AI despite the company&#8217;s stock falling after reporting mixed fourth-quarter results.



Ark Invest&#8217;s ARK Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) bought 268,467 shares of Recursion Pharmaceuticals and 32,467 shares of Tempus AI.



The ARK Innovation ETF acquired 384,956 shares of Recursion Pharmaceuticals and 49,250 shares of Tempus AI.



Given the closing prices of $56.18 for Tempus AI and $7.51 for Recursion Pharmaceuticals, the total value of these trades is $36.7 million and $0.61 million, respectively.



The IRDM, TWST, ADYEY, ACCD, and EXAS Trades



Ark Invest&#8217;s ARK Innovation ETF bought 73,659 shares of&nbsp;Iridium Communications Inc, while selling 65,290 shares of&nbsp;Twist Bioscience Corp.



The ARK Next Generation Internet ETF sold a small number of shares (52) of&nbsp;Adyen NV.



The ARK Genomic Revolution ETF sold 80,270 shares of&nbsp;Exact Sciences Corp&nbsp;and a minor quantity (232) of&nbsp;Accolade Inc&nbsp;shares.



Read Next:



<ul>
<li><a href="https://www.benzinga.com/25/02/43900360/bill-gates-has-a-warning-for-the-next-generation-says-be-very-afraid-of-these-4-issues" target="_blank" rel="noreferrer noopener">Bill Gates Has A Warning For The Next Generation, Says Be ‘Very Afraid' Of These 4 Issues</a></li>
</ul>



Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.



Image via Ark Invest

Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday

On Friday, Cathie Wood-led Ark Invest made significant trades involving CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), 10X Genomics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>), Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), Archer Aviation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>), Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), Adyen NV (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>), Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and AeroVironment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>).



The CRSP Trade



Ark Invest purchased shares of CRISPR Therapeutics AG for both its ARK Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>). The ARKG ETF bought 43,467 shares, while the ARKK ETF acquired 248,748 shares.



Based on the closing price of $41.59 on the same day, the total value of the purchased shares amounts to approximately $12.14 million.



The TXG Trade



Another significant buy was 10X Genomics. Ark Invest added 11,137 shares to its ARKG ETF and 63,395 shares to its ARKK ETF. Given the closing price of $15.00, the total value of the purchased shares is around $1.12 million.



The RBLX and ACHR Trades



On the sell side, Ark Invest reduced its holdings in Roblox Corp. and Archer Aviation. The firm sold 46,459 shares of RBLX and 374,904 shares of ACHR from its ARKK ETF. Based on the closing prices of $71.07 and $9.45 respectively, the total value of the sold shares is approximately $4.12 million.



Other Key Trades:



Ark Invest sold 307,632 shares of Accolade Inc. from its ARKG ETF.



The firm also reduced its holdings in Nu Holdings and Adyen NV from its ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>), selling 300 and 5,600 shares respectively.



From its ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>), Ark Invest sold 2,671 shares of AeroVironment Inc.



These trades provide a glimpse into Ark Invest&#8217;s strategy and the sectors it is currently focusing on. The firm&#8217;s moves are closely watched by investors due to its strong historical performance.



&nbsp;Read Next:



<a href="https://www.benzinga.com/25/01/43373954/cathie-woods-ark-invest-dumps-over-10-million-worth-of-palantir-stock-as-ai-competition-heats-up">Cathie Wood&#8217;s Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats U</a>



Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.



Photo courtesy: Ark Invest

Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox

BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) shares have outperformed the Zacks Computer &amp; Technology sector and its Zacks Internet - Software industry peer Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) in the past month.

While BILL has moved up 5.7%, Intuit has risen 0.3%. The broader sector has dropped 0.8% over the same timeframe.

BILL&#39;s robust price performance has been driven by its impressive fiscal fourth-quarter 2024 results.

It registered 16% year-over-year growth in revenues. Core revenues, which included subscription and transaction fees, also rose 16% to $301 million. The upside was supported by BILL&#39;s ability to acquire new customers and expand its payment offerings.

<div class="chart_embed">
<h3>BILL Holdings, Inc. Price and Consensus</h3>

<img alt="BILL Holdings, Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/c0/1726494702.png" style="height:283px; width:620px" title="" />

BILL Holdings, Inc. price-consensus-chart &#x7C; BILL Holdings, Inc. Quote

BILL added a total of 11,300 net new customers in fourth-quarter fiscal 2024, with 4,600 customers from its direct and accounting channels and 6,700 from financial institutions. The retention rate for BILL standalone customers was 83%, demonstrating strong customer loyalty.

Nevertheless, investors should ask this question &mdash; will expanding clientele make BILL shares a good investment? Let&#39;s analyze.
</div>

<h3>Will BILL&#39;s Strong Portfolio Aid Prospect?</h3>

BILL is solidifying its position in the financial technology landscape with a growing portfolio and strong momentum across its Spend &amp; Expense solution.

In fourth-quarter fiscal 2024, BILL upgraded its payment engine and platform, revamped its mobile app and added local transfer options for international payments and FedNow support for instant transfers. This shows BILL&#39;s dedication to enhancing its financial solutions.

In the same quarter, its solutions were utilized by 475,600 businesses and transacted $76 billion in total payment volume.

The Spend and Expense solution (formerly known as Divvy) saw revenue growth of 26%, driven by a 28% increase in card payment volume. This solution added 1,300 net new businesses in fourth-quarter fiscal 2024.

BILL&#39;s expanding SMB clientele with the likes of Adyen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>), Regions Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) and Xero has been a key catalyst.

In June, the company partnered with Regions Bank to launch Regions CashFlowIQSM, a digital solution designed to streamline payments and enhance cash-management processes for commercial clients.

BILL&#39;s partnership with Adyen integrates advanced acquiring and issuing capabilities into its financial operations platform for SMBs, enhancing accounts payable and receivable solutions with Adyen&#39;s technology.

<h3>BILL&#39;s Q1 Outlook Looks Dull</h3>

Bill Holdings&#39; strong demand for its financial operations platform among SMBs is boosting top-line growth. However, a challenging macroeconomic environment, persistent inflation and high interest rates are a major concern as SMBs tighten their spending budgets on digital initiatives.

For first-quarter fiscal 2025, BILL expects revenues to be between $346 million and $351 million, indicating growth of 13-15% year over year. The Zacks Consensus Estimate is pegged at $348.07 million, suggesting a rise of 14.13% year over year.

Non-GAAP earnings per share are expected to be between 48 cents and 51 cents. The consensus mark for earnings declined 5.7% in the past 30 days to 49 cents.

<h3>BILL Stock &ndash; Buy, Sell or Hold?</h3>

BILL stock is not so cheap, as the Value Score of D suggests a stretched valuation at this moment.

The forward 12-month Price/Sales ratio for BILL stands at 4.32X, higher than its Zacks Internet - Software sector&#39;s 3.12X, reflecting a stretched valuation.

BILL Holdings currently carries Zacks Rank #3 (Hold) suggesting that it may be wise to wait for a more favorable entry point in the stock.

<a href="https://www.zacks.com/stock/news/2336690/bill-surges-6-in-a-month-should-you-buy-hold-or-sell-the-stock?cid=CS-BENZ-FT-analyst_blog&#x7C;rank_focused-2336690">To read this article on Zacks.com click here.</a>

Earnings

Large Cap

Mid Cap

Offerings

BILL

INTU

BILL Surges 6% in a Month: Should You Buy, Hold or Sell the Stock?

BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) is scheduled to report third-quarter fiscal 2024 results on May 2. 
BILL Holdings&#39; third-quarter fiscal 2024 revenues are projected between $299 million and $309 million, suggesting year-over-year growth of 10-13%. Non-GAAP earnings are expected between 48 cents and 57 cents per share. 
The Zacks Consensus Estimate for revenues is pegged at $304.95 million, suggesting an increase of 11.88% from the year-ago quarter&#39;s reported number. 
The consensus mark for third-quarter fiscal 2024 earnings is pegged at 53 cents per share, unchanged in the past 30 days.

<div class="chart_embed">
<h3>BILL Holdings, Inc. Price and EPS Surprise</h3>

<a href="https://www.zacks.com/stock/chart/BILL/price-eps-surprise?icid=chart-BILL-price-eps-surprise"><img alt="BILL Holdings, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/1a/1714487772.png" style="height:299px; width:620px" title="" /> </a>

BILL Holdings, Inc. price-eps-surprise &#x7C; BILL Holdings, Inc. Quote
</div>

BILL Holdings beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average surprise being 53.47%. 
Let&#39;s see how things have shaped up for BILL prior to this announcement.

<h3>Factors to Note</h3>

BILL Holdings&#39; third-quarter fiscal 2024 performance is expected to have benefited from an expanding small and medium business (ETF:SMB) clientele as well as a diversified business model.&nbsp;

The company&#39;s expanding clientele, which includes the likes of Adyen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>), is expected to have driven solid traction across small- and medium-scale businesses.&nbsp;

BILL&#39;s partnership with Adyen will enable the latter to enhance advanced acquiring and issuing experiences for BILL&#39;s accounts payable and accounts receivable solutions. Benefits from this partnership are likely to have been reflected in the quarter under review.&nbsp;

Bill&#39;s expanding portfolio to meet the evolving needs of its customers is expected to have been a major growth driver in the to-be-reported quarter.&nbsp;&nbsp;

Strong momentum across its financial operations platform, owing to its BILL Insights and BILL Cash Flow Forecasting solutions for SMBs and accountants, is likely to have been a tailwind.&nbsp;

In the second quarter of fiscal 2024, BILL launched its new integrated platform, which combines its BILL AP and Divvy Spend and Expense Solutions to offer a unified customer experience. The increased adoption of this integrated platform is expected to have contributed to revenue growth as more businesses utilize the platform for their financial operations.&nbsp;

BILL is also leveraging artificial intelligence that makes its solutions easier to use, more automated and predicted. It is working on integrating generative AI in its solutions to enhance customer experience. This is likely to have contributed well in the quarter under review.&nbsp;

Additionally, BILL&#39;s efforts to enrich payment experiences and drive penetration of its ad valorem solutions, such as virtual cards, instant transfers and invoice financing, are expected to have contributed to revenues by capturing more wallet share and increasing payment adoption among its customers and network members.

<h3>What Our Model Says</h3>

Per the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that&#39;s not the case here. 
BILL Holdings currently has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they&#39;re reported with our Earnings ESP Filter.

<h3>Stocks to Consider</h3>

Here are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases: 
Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) has an Earnings ESP of +2.49% and a Zacks Rank #1. 
Arista Networks&#39; shares have gained 12% year to date. ANET is set to report its first-quarter 2024 results on May 7. 
NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has an Earnings ESP of +2.50% and a Zacks Rank #2. 
NVIDIA&#39;s shares have gained 203.5% year to date. NVDA is scheduled to release first-quarter fiscal 2025 results on May 22.

<a href="https://www.zacks.com/stock/news/2265385/bill-holdings-bill-to-report-q3-earnings-what-s-in-store?cid=CS-BENZ-FT-analyst_blog&#x7C;earnings_preview-2265385">To read this article on Zacks.com click here.</a>

ANET

NVDA

BILL Holdings to Report Q3 Earnings: What's in Store?

Understanding a company&#39;s quarterly earnings is vital for investors, analysts, and consumers. These reports offer a snapshot of a company&#39;s financial performance over three months, revealing its stability and growth potential.

In the US, there&#39;s an SEC requirement for companies to post earnings every quarter, but this isn&#39;t a global mandate. Some companies, like Adyen N.V (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>)&nbsp;report earnings only every six months. Not all companies conduct earnings calls, as it&#39;s at their discretion. For example, Warren Buffett&#39;s Berkshire Hathaway Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brk-b#NYSE">BRK-B</a>)&nbsp;avoids quarterly commentary to maintain independence from Wall Street.

Quarterly earnings reports serve multiple purposes:

1. Investment Decisions: Investors rely on these reports to make informed choices. Positive earnings indicate profitability, potentially boosting stock prices, while negative earnings prompt reevaluation of investment strategies.

2. Analyst Assessments: Analysts use these reports to evaluate a company&#39;s management efficiency and strategies. By comparing earnings to past quarters and industry benchmarks, they gauge the company&#39;s financial performance and provide recommendations to investors, influencing the stock market and the company&#39;s reputation.

3. Consumer Impact: Consumers also benefit from understanding quarterly earnings, which can impact their purchasing decisions. Companies with positive earnings are more likely to invest in research and development, leading to improved products and services. Conversely, companies struggling with earnings might reduce innovations, affecting product quality or customer service.

In summary, comprehending quarterly earnings is crucial for investors making investment choices, analysts evaluating strategies, and consumers gauging a company&#39;s overall health and product/service quality.

To effectively review earnings, a checklist is recommended. It helps maintain consistency and track performance. Keeping an earnings journal is also beneficial for recording thoughts. Various tools like Journalytic, Excel, Word, Google Sheets, or Docs can be used to create checklists and journals.

Here&#39;s a comprehensive checklist for reviewing earnings:

1. Gathering Earnings Reports 2. Analyzing Revenue Performance 3. Analyzing Profits Using Metrics 4. Examining EPS (Earnings per share) Performance 5. Investigating Free Cash Flow (FCF) 6. Understanding Forward Guidance 7. Analyzing Management Commentary 8. Considering Qualitative Factors

Each step is crucial in dissecting a company&#39;s performance and understanding its future prospects.

For example, let&#39;s walk through these steps using Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) as an example:

Step 1: Gathering Earnings Reports involves accessing the 10-Q, press release, transcript of earnings calls, and earnings slides. These free resources provide essential information.

Step 2: Analyzing Revenue Performance requires assessing both short-term and long-term trends. Investigating revenue drops is crucial, and the earnings call transcript can provide insights into management&#39;s understanding of the issue.

Step 3: Analyzing Profits Using Metrics involves calculating ratios or using financial websites like Stratosphere. In the case of Texas Instruments, there&#39;s downward pressure on various margins that warrants further investigation.

Step 4: Examining EPS Performance. Checking if heavy share buybacks are masking net income trends is important.&nbsp;

Step 5: Investigating Free Cash Flow is critical, as it dictates a company&#39;s ability to reinvest and make capital decisions. For Texas Instruments, there&#39;s been a significant fall in free cash flow that needs exploration.

Step 6: Understanding Forward Guidance. Companies like Texas Instruments often provide guidance on future revenue and earnings in press releases. It&#39;s important to analyze if they meet these forecasts.

Step 7: Analyzing Management Commentary provides insights into a company&#39;s outlook, plans, and expectations. Honest companies will discuss challenges and performance gaps.

Step 8: Considering Qualitative Factors involves assessing the company&#39;s performance relative to others in the industry, listening to competitors&#39; earnings calls, and evaluating market sentiment.

In conclusion, quarterly earnings reports are pivotal for investors, providing timely insights into a company&#39;s financial performance and direction. These reports empower investors to make prudent investment choices, manage risk effectively, and adapt their portfolios to changing market dynamics.

BRK-B

8 Easy Steps To Analyzing A Company's Quarterly Report

Dutch payment technology giant&nbsp;Adyen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) nabbed a banking license in the U.K., enabling its merchants to offer cash advances to small and medium-sized enterprises there. &nbsp;

Adyen is used by several high-profile companies including Microsoft, Instacart&nbsp;and Subway as an all-in-one payment processor.

&ldquo;It will strengthen our ability to help domestic and international businesses achieve their ambitions faster. It&rsquo;s another stride towards Adyen becoming a full spectrum global financial technology platform,&rdquo; said Mari&euml;tte Swart, Adyen&rsquo;s chief legal and compliance officer.

Read Here: <a href="https://www.benzinga.com/markets/cryptocurrency/23/09/34281419/faas-market-will-soar-to-1t-crypto-asset-management-to-reach-3-1b-new-economic-titans" style="color:#0563c1; text-decoration:underline">Fintech Market Will Soar To $1T, Crypto Asset Management To Reach $3.1B: New Economic Titans</a>

License, in Detail: Adyen announced&nbsp;the license would let it continue to operate under the U.K.&rsquo;s Temporary Permissions Regime wherein it can provide services in line with its E.U. business, post-Brexit. &nbsp;

The license also allows Adyen to continue to offer its recently launched embedded financial product suite in the U.K. The suite includes bank accounts, virtual or physical cards for simplified cash flow and expense management.

Adyen has a license in the Netherlands as an acquiring bank under which it can process merchant payments almost instantly rather than seek banking partners who take several days to do the same.

Cathie Wood and Ark Invest Interest: In the last week of August, Cathie Wood made a significant investment in Adyen with ARK Invest purchasing around 2,889 shares of Adyen NV through ARK&nbsp;Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) and around 733,462&nbsp;U.S.-traded depository receipts through ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>).

Read Next:&nbsp;<a href="https://www.benzinga.com/news/large-cap/23/09/34326552/exclusive-is-cathie-wood-using-chatgpt-to-pick-stocks">EXCLUSIVE: Is Cathie Wood Using ChatGPT To Pick Stocks?</a>

With Adyen being a prominent Fintech player, Benzinga&#39;s exclusive event,&nbsp;<a href="https://www.benzinga.com/go/crypto-conference-article-link" style="color:#0563c1; text-decoration:underline" target="_blank">Future of Digital Assets</a>&nbsp;is where&nbsp;<a href="https://www.benzinga.com/go/crypto-conference-article-link" style="color:#0563c1; text-decoration:underline" target="_blank">Digital Asset and Crypto</a>&nbsp;business leaders and investors will meet is a good platform to know what the other Fintech companies are up to. Tickets are flying:&nbsp;<a href="https://www.benzinga.com/go/crypto-conference-article-link" style="color:#0563c1; text-decoration:underline" target="_blank">Get&nbsp;yours</a>!

Photo: Shutterstock

UK Grants Banking License To Amsterdam-Based Adyen, Which Saw Recent Interest From Cathie Wood's ARK Invest

On Monday, August 21, 2023, Cathie Wood-led Ark Invest made significant moves in the market, with a notable decision to sell $9.2 million worth of shares of Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>). This comes in the wake of Shopify's recent volatility following its Q2 results.



The Shopify Trade: Ark sold 170335 shares of Shopify through ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>) and Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>). The transaction was valued at $9.2 million, based on Shopify stock&#8217;s closing price of $53.93 on Monday.



Ark Invest&#8217;s decision to sell Shopify shares across various ETFs is a continuation of its recent trading behavior.



Earlier this week, Ark Invest also made a notable decision to sell Shopify shares. All in all, Ark sold $8.9 million of Shopify shares.



Wood-led Ark Invest also made a significant investment in <a href="38">Adyen N.V.</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYYF#OTC">ADYYF</a>), a Dutch payment company, on Monday. Ark Invest bought 2889 shares of ADYEN NV (ADYEN.AS) through ARKF and 733,462 shares through ARKW.



See Also: <a href="https://www.benzinga.com/etfs/specialty-etfs/23/08/33966459/is-nvidia-overpriced-cathie-woods-ark-invest-points-to-3-other-stocks">Is Nvidia Overpriced? Cathie Wood&#8217;s Ark Invest Points To 3 Other Stocks</a>



Other Key Trades:



<ul>
<li>Ark Invest bought 7017 shares of CRISPR THERAPEUTICS AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>) through ARK Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>).</li>



<li>Ark Invest bought 32165 shares of ADAPTIVE BIOTECHNOLOGIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) through ARKG.</li>



<li>Ark Invest bought 37638 shares of RECURSION PHARMACEUTICALS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) through ARKG.</li>



<li>Ark Invest sold 249538 shares of CODEXIS INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) through ARKG.</li>



<li>Ark Invest sold 249507 shares of PHENOMEX INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELL#NASDAQ">CELL</a>) through ARKG.</li>
</ul>



Read Next: <a href="https://www.benzinga.com/markets/equities/23/08/33651868/palantir-post-q2-earnings-share-price-dip-doesnt-deter-cathie-wood-ark-invest-buys-14m-worth-of-">Palantir Post-Q2 Earnings: Share Price Dip Doesn&#8217;t Deter Cathie Wood; Ark Invest Buys $14M Worth Of Shares</a>



<div style="font-family: 'Lato', sans-serif">
 <div>
 <hr style="border: 0;height: 5px;background: #225aa9">
 <div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>
 
 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Shivdeep Dhaliwal</a>
 
 
 <hr style="border: 0;height: 1px;background: #225aa9">
 
 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you.
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
 <hr style="border: 0;height: 5px;background: #225aa9">
 </div>
</div>

Media

ADPT

ADYYF

CDXS

CELL

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead

<ul>
	<li>Stripe&nbsp;Inc&nbsp;co-founders Patrick and John Collison internally shared their goal of either taking the company public or allowing employees to sell shares in a private-market transaction within the next 12 months.</li>
	<li>Stripe hired&nbsp;Goldman Sachs Group, Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and&nbsp;JP Morgan Chase &amp; Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) for advice, the Wall Street Journal&nbsp;<a class="editor-rtfLink" href="https://www.wsj.com/articles/stripe-sets-one-year-timetable-to-decide-on-going-public-11674749304?mod=tech_lead_pos7" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">reports</a>.</li>
	<li>Stripe is a payments processor to internet companies like&nbsp;Shopify Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) and&nbsp;Instacart Inc.</li>
	<li>Stripe&#39;s last fundraising nearly two years ago valued the company at $95 billion.&nbsp;</li>
	<li>Recently, Stripe approached investors, including&nbsp;Berkshire Hathaway Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brk-b#NYSE">BRK-B</a>), about raising at least $2 billion at a valuation of $55 billion - $60 billion.</li>
	<li>Stripe laid off 14% of its workforce in November. The Collison brothers admitted overestimating the internet economy&#39;s near-term prospects.&nbsp;</li>
	<li>A pandemic-fueled boom in e-commerce led to Stripe recording annual revenue increasing nearly 70% to about $7.4 billion in 2020.</li>
	<li>However, 2021 appeared more challenging as consumers returned to in-store shopping and changed their spending patterns in the face of high inflation.</li>
	<li>Last July, Stripe cut its internal share price to price stock options given to employees to $29 from $40, lowering the company&#39;s valuation to $74 billion.&nbsp;</li>
	<li>Stripe recently cut the value of those shares again to $25, giving&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/23/01/30384683/payments-firm-stripe-cuts-valuation-by-11-again" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">the company a valuation of $63 billion</a>.</li>
	<li>In 2022, Stripe decided to offer customers access to&nbsp;Bitcoin&nbsp;four years after suspending support for the cryptocurrency, taking a cue from rivals.</li>
</ul>

IPOs

Payments Processor Stripe Harbors IPO Ambitions

On Monday, shares of Adyen N.V. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) experienced volatile short activity. After the activity, the stock price went down -9.13% to $16.22.

The overall sentiment for ADYEY has been Bearish.

The signal from the volatility alert is trending Bearish. Therefore, the recommendation is to Increase Short Exposure.

The volatility alert was produced on the prior trading date, 8/22/2022 with a volatility change of +69.55%. The current volatility indicator stands at 12.580.

Overview: The securities lending volatility indicator is produced by Tidal Markets, in partnership with Benzinga Insights. Securities lending primarily serves the purpose of providing liquidity to short sellers. When unusual activity occurs in the securities lending markets, it acts as an upstream indicator to what is likely to occur downstream in the regular stock market.

Understanding the Volatility Alert: Overall sentiment is considered &quot;bear&quot; when broad market activity of the stock has been shown to indicate a negative directional basis, or is considered &quot;bull&quot; when indicating a positive directional basis. The securities lending volatility indicator provides a signal when it detects unusual short activity. Unusual short activity is based off a computer generated algorithmic formula utilizing securities lending trade details such as the volume of shares being shorted, the rate being paid to short the shares, and the type of collateral being posted - amongst other variables. The current volatility is the respective trading day&#39;s calculated securities lending volatility value. The volatility percentage change is the percentage difference in volatility between the two most recent days. The recommendation is a suggestive strategy, inferred from the strength of the Signal Trending, Current Volatility, and Volatility % Change. Recommendations may include, &quot;Strong Buy&quot;, &quot;Strong Sell&quot;, &quot;Increase Short Exposure&quot;, &quot;Decrease Short Exposure&quot;, or &quot;Market Neutral&quot;.

ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE &nbsp;

Short Ideas

Short Volatility Alert: Adyen N.V.

On Monday, shares of Adyen N.V. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) experienced volatile short activity. After the activity, the stock price went down -0.94% to $14.80.

The overall sentiment for ADYEY has been Bearish.

The signal from the volatility alert is trending Bullish. Therefore, the recommendation is to Decrease Short Exposure.

The volatility alert was produced on the prior trading date, 7/11/2022, with a volatility change of +79.40%. The current volatility indicator stands at 13.367.&nbsp;

Overview:
The securities lending volatility indicator is produced by Tidal Markets, in partnership with Benzinga Insights. Securities lending primarily serves the purpose of providing liquidity to short sellers. When unusual activity occurs in the securities lending markets, it acts as an upstream indicator to what is likely to occur downstream in the regular stock market.

Understanding the Volatility Alert:
Overall sentiment is considered &quot;bear&quot; when broad market activity of the stock has been shown to indicate a negative directional basis, or is considered &quot;bull&quot; when indicating a positive directional basis. The securities lending volatility indicator provides a signal when it detects unusual short activity. Unusual short activity is based off a computer generated algorithmic formula utilizing securities lending trade details such as the volume of shares being shorted, the rate being paid to short the shares, and the type of collateral being posted - amongst other variables. The current volatility is the respective trading day&#39;s calculated securities lending volatility value. The volatility percentage change is the percentage difference in volatility between the two most recent days. The recommendation is a suggestive strategy, inferred from the strength of the Signal Trending, Current Volatility, and Volatility % Change. Recommendations may include, &quot;Strong Buy&quot;, &quot;Strong Sell&quot;, &quot;Increase Short Exposure&quot;, &quot;Decrease Short Exposure&quot;, or &quot;Market Neutral&quot;.

ANY INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR IMPLY INVESTMENT ADVICE

<ul>
	<li>McDonald&#39;s Corp&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>)&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/22/06/n27811076/adyen-and-mcdonalds-expand-mobile-app-partnership-to-the-u-s" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">has expanded its mobile app partnership</a>&nbsp;with financial technology platform&nbsp;Adyen&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) to the U.S.</li>
	<li>The two companies began working together in early 2020 in the U.K. and are now expanding to other global markets.</li>
	<li>Adyen enables customers to pay with their saved payment method on the McDonald&#39;s mobile app at the front counter, kiosk, or drive-thru using a four-digit code, providing convenience and supporting operational speed.</li>
	<li>&quot;Adyen has handled mobile volumes during peak events, such as promotions and rush times. Additionally, they helped improve the success rate for customers registering their preferred payment types to their digital profile and reduced card declines during order placement by using Real-time Account Updater technology,&quot; said Whitney McGinnis, U.S. CIO at McDonald&#39;s.</li>
	<li>Price Action:&nbsp;MCD shares are trading higher by 1.55% at $243.31 on the last check Wednesday.</li>
	<li>Photo Via Wikimedia Commons</li>
</ul>

Adyen, McDonald's Extend Mobile App Partnership To US

Upgrades

Downgrades

Initiation

Intraday Update

AEVA

APLS

ATRS

BBBY

CMBM

CTVA

CVLG

DRTS

ENJY

ENPH

ESTE

FORA

GDDY

GRPH

HCAT

HIMS

HRMY

HYPR

INVH

LAZR

NXGN

PAGS

PINC

PSFE

PTVE

RPRX

SAIL

SEDG

SIEN

SRRA

TALO

TWTR

USNA

VSTM

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022

Piper Sandler analyst Christopher Donat initiates coverage on Adyen (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>) with a Overweight rating.

Piper Sandler Initiates Coverage On Adyen with Overweight Rating

On <a href="https://www.cnbc.com/video/2021/08/20/final-trades-inda-adyey-mrvl-cybr.html">CNBC&#39;s &quot;Fast Money Final Trade,&quot;</a> Tim Seymour recommended a long position in iShares MSCI India ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/INDA#BATS">INDA</a>).

Nadine Terman wants to buy Adyen Unsponsored Netherl 50 ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>).

Pete Najarian said Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) has got a lot more room to the upside. He is a buyer.

Brian Kelly is bullish on Cyberark Software Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>).

CYBR

INDA

MRVL

'Fast Money' Picks For August 23

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) after the company posted its first operating loss as a listed company, as a record regulatory fine it was <a href="https://www.benzinga.com/news/21/04/20571657/why-is-alibaba-stock-surging-despite-2-87b-antitrust-fine" style="text-decoration:none">slapped</a> with last month weighed on its earnings.

Shares of Alibaba, the e-commerce company that runs China&rsquo;s most visited online marketplaces Taobao and Tmall, closed 6.28% lower at $206.08 on Thursday.

The ARK Fintech Innovation&nbsp;ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)&nbsp; made the trade,&nbsp;ahead of which It held 422,896 shares, worth about $92.99 million in Alibaba.

See Also: <a href="https://www.benzinga.com/fintech/21/04/20828550/ant-troubles-not-over-jack-mas-relations-with-regulators-said-to-be-under-beijing-scrutiny" style="text-decoration:none">Ant Troubles Not Over? Jack Ma&#39;s Relations With Regulators Said To Be Under Beijing Scrutiny</a>

Besides ARKF, the hedge fund also holds Alibaba via the ARK Autonomous Technology &amp; Robotics ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>) and the ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>).

Wood&#39;s firm has been <a href="http://www.benzinga.com/trading-ideas/long-ideas/21/05/20833496/cathie-wood-cant-get-enough-of-these-3-chinese-alibaba-rivals" style="text-decoration:none">piling up shares in Alibaba rivals</a> including Pinduoduo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and JD.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>).

Other Ark Buys On Thursday:

<ul>
	<li>Zillow Group Inc Class A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>)</li>
	<li>Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)</li>
	<li>DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)</li>
	<li>Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>)</li>
	<li>Square Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>)</li>
	<li>Repare Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)</li>
	<li>Recursion Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>)</li>
	<li>908 Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>)</li>
	<li>Uipath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>)</li>
	<li>1life Healthcare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEM#NASDAQ">ONEM</a>)</li>
	<li>Exact Sciences Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>)</li>
	<li>Ionis Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>)</li>
	<li>Butterfly Network Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>)</li>
	<li>Butterfly Network Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>)</li>
	<li>Signify Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGFY#NYSE">SGFY</a>)</li>
	<li>Zymergen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZY#NASDAQ">ZY</a>)</li>
	<li>Codexis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>)</li>
	<li>CM Life Sciences II Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMII#NASDAQ">CMII</a>)</li>
	<li>Twilio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)</li>
	<li>Pacific Biosciences of California Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>)</li>
	<li>TuSimple Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSP#NASDAQ">TSP</a>)</li>
	<li>Unity Software Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>)</li>
	<li>Crispr Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>)</li>
	<li>Zoom Video Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)</li>
	<li>Beam Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>)</li>
	<li>Skillz Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>)&nbsp;</li>
	<li>Kratos Defense &amp; Security Solutions Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>)</li>
	<li>Iridium Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>)</li>
	<li>The 3D Printing ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/PRNT#BATS">PRNT</a>)</li>
</ul>

Other Ark Sells On Thursday:

<ul>
	<li>Yeahka Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/YHEKF#OTC">YHEKF</a>)</li>
	<li>Silvergate Capital Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SI#NYSE">SI</a>)</li>
	<li>Takeda Pharmaceutical Co Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAK#NYSE">TAK</a>)</li>
	<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>)</li>
	<li>Thermo Fisher Scientific Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>)</li>
	<li>Syros Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>)</li>
	<li>Sarepta Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>)</li>
	<li>Roche Holding Ag (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>)</li>
	<li>Pluristem Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTI#NASDAQ">PSTI</a>)</li>
	<li>Regeneron Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)</li>
	<li>Phreesia Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>)</li>
	<li>Bristol-Myers Squibb Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</li>
	<li>Lendingtree Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>)</li>
	<li>Synopsys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>)</li>
	<li>Pure Storage Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>)</li>
	<li>Novartis Ag (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>)</li>
	<li>Paccar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>)</li>
	<li>Intercontinental Exchange Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>)</li>
	<li>Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)</li>
	<li>KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)</li>
	<li>PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>)</li>
	<li>Pinterest Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)</li>
	<li>Nvdia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</li>
	<li>Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)</li>
	<li>HubSpot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>)</li>
	<li>Fastly Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>)</li>
	<li>Docusign Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>)</li>
	<li>Crowdstrike Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)</li>
	<li>Workhorse Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>)</li>
	<li>Adyen NV (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>)</li>
</ul>

<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/NUehKZBLBCQ" width="560"></iframe>

Penny Stocks

Sector ETFs

Small Cap

BABA

BEAM

BEKE

BFLY

BIDU

CMII

COIN

CRWD

DKNG

DOCU

FSLY

HUBS

IONS

KTOS

MASS

NFLX

ONEM

PACB

PATH

PCAR

PINS

PRNT

PSTG

PSTI

REGN

RHHBY

RPTX

SGFY

SKLZ

SNPS

SRPT

SYRS

TREE

TWLO

VRTX

WKHS

YHEKF

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day

Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) after the data analytics company reported strong earnings on Tuesday.

Shares of Palantir, which reported earnings before the market opened, were down to about $16.50 in premarket trading on Tuesday before staging a reversal that saw the stock close up 9.42% at $20.21. The shares were further up 2.3% in extended hours.

The trades were made through Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) and the&nbsp;ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>), which together held PLTR shares, worth about $414 million, ahead of Tuesday&rsquo;s trade.

No other Ark ETF has a position in Palantir.&nbsp;

The New York-based investment firm had on Monday also snapped up 1.36 million shares in Palantir.

See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21073150/palantir-stages-reversal-following-phenomenal-earnings-report-says-roger-monteforte">Palantir Stages Reversal Following &#39;Phenomenal&#39; Earnings Report, Says Roger Monteforte</a>

Palantir reported first-quarter earnings of 4 cents per share on Tuesday, which was in line with the consensus estimate. Revenue grew 49% year-over-year to $341 million, which beat the estimate of $332.23 million. Palantir also reaffirmed its guidance for annual revenue growth of 30% or greater through 2025.&nbsp;

On the conference call, the company said it would begin accepting Bitcoin as payment from customers. Further, Palantir said it&#39;s considering investing in Bitcoin or other cryptocurrencies.

See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/21/05/21050757/cathie-wood-cuts-apple-stake-by-30-and-buys-coinbase-draftkings">Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings</a>

Other Ark Buys On Tuesday:

<ul>
	<li>Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)</li>
	<li>Veracyte Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>)</li>
	<li>908 Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>)</li>
	<li>Repare Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPTX#NASDAQ">RPTX</a>)</li>
	<li>Ionis Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>)</li>
	<li>Adaptive Biotechnologies Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>)</li>
	<li>CM Life Sciences II Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMII#NASDAQ">CMII</a>)</li>
	<li>CareDx Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>)</li>
	<li>Codexis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>)</li>
	<li>Uipath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>)</li>
	<li>Roku Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)</li>
	<li>Shopify Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>)</li>
	<li>Spotify Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>)</li>
	<li>TuSimple Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSP#NASDAQ">TSP</a>)</li>
	<li>Unity Software Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>)</li>
	<li>Zoom Video Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)</li>
	<li>Pacific Biosciences of California Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>)</li>
	<li>Beam Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>)</li>
	<li>Berkeley Lights Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLI#NASDAQ">BLI</a>)</li>
	<li>Fate Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>)</li>
	<li>DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>)</li>
	<li>Crispr Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>)</li>
	<li>One (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AONE#NYSE">AONE</a>)</li>
	<li>Kratos Defense &amp; Security Solutions Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>)</li>
	<li>Iridium Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>)</li>
	<li>The 3D Printing ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/PRNT#BATS">PRNT</a>)</li>
	<li>Teradyne Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>)</li>
	<li>JD.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)</li>
	<li>&nbsp;</li>
</ul>

Other Ark Sells On Tuesday:

<ul>
	<li>Yeahka Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/YHEKF#OTC">YHEKF</a>)</li>
	<li>Silvergate Capital Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SI#NYSE">SI</a>)</li>
	<li>Phreesia Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>)</li>
	<li>Syros Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>)</li>
	<li>Nanostring Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSTG#NASDAQ">NSTG</a>)</li>
	<li>Sarepta Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>)</li>
	<li>Roche Holding Ag (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>)</li>
	<li>Pluristem Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTI#NASDAQ">PSTI</a>)</li>
	<li>KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)</li>
	<li>Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)</li>
	<li>Lendingtree Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>)</li>
	<li>Synopsys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>)</li>
	<li>Novartis Ag (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>)</li>
	<li>Regeneron Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)</li>
	<li>Nintendo Co Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTDOY#NASDAQ">NTDOY</a>)</li>
	<li>Huya Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUYA#NYSE">HUYA</a>)</li>
	<li>Organovo Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>)</li>
	<li>Komatsu Ltd (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KMTUY#OTC">KMTUY</a>)</li>
	<li>Workhorse Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>)</li>
	<li>Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</li>
	<li>Intercontinental Exchange Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>)</li>
	<li>Agora Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>)</li>
	<li>Adyen Nv (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADYEY#OTC">ADYEY</a>)</li>
	<li>LendingTree Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>)</li>
	<li>Virgin Galactic Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>)</li>
	<li>Deere &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>)</li>
</ul>

<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/NUehKZBLBCQ" width="560"></iframe>

Photo by Tech.Co on Flickr

AONE

CDNA

FATE

GOOGL

HUYA

KMTUY

NSTG

NTDOY

ONVO

PLTR

ROKU

Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat